News

Patients who received oral tranexamic acid 500 mg daily for 3 months had reduced melasma severity and systemic inflammation markers.
HealthDay News — Dozens of people in northeastern England have developed a rare and dangerous illness after receiving Botox injections, according to health officials in the U.K.
The intensity of CKD-aP is linked to levels of systemic inflammation, with reductions in these levels seen with difelikefalin treatment.
The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), ...
Results of an autopsy-based study revealed that sudden cardiac death and multiorgan pathology may be more closely linked to SSc than previously thought.
Experienced epidemiologist Dr Fiona Havers resigned from the CDC due to her lack of confidence in the current leadership.
The LGBTQ+ specialized subprogram of the 988 National Suicide and Crisis Lifeline will no longer be available after July 17, 2025.
Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.
The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.
Early childhood atopic dermatitis does not affect executive function during middle childhood, particularly in those with mild phenotypes.
Keytruda (pembrolizumab) is approved for head and neck squamous cell carcinoma as a perioperative treatment regimen.
Mismatch repair germline alterations occur frequently in uveal melanoma, suggesting it could be part of the Lynch syndrome spectrum.